Not finding it? Sign in to also search OpenAlex live.
-
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial2022 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Extracellular vesicles in disease Open access
Timothy Wai Ho Shuen, Marianna Alunni‐Fabbroni, Elif Öcal, Peter Malfertheiner, Moritz Wildgruber, Regina Schinner, +8 more
40citations -
The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitro2022 Journal of Cellular and Molecular Medicine article Medicine Glioma Diagnosis and Treatment Open access
Leonie F. Schoen, Rogerio Bastos Craveiro, Torsten Pietsch, Thomas Moritz, Anja Troeger, Silvia Jordans, +1 more
9citations -
191P Evaluating sorafenib as second-line treatment for advanced hepatocellular carcinoma: SORA-2, an European retrospective multicenter study2024 Annals of Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Christian Möhring, Moritz Berger, Farsaneh Sadeghlar, M-L. Berres, I-P. Radu, Christoph Roderburg, +11 more
1citations -
Impact of viral aetiology in the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC)2023 Zeitschrift für Gastroenterologie article Medicine Hepatocellular Carcinoma Treatment and Prognosis
Marie‐Luise Berres, Stephen Lam Chan, Masatoshi Kudo, Bruno Sangro, Robin Kate Kelley, Junji Furuse, +15 more
0citations -
Experimental mouse model of hepatocellular carcinoma with and without parenchymal liver damage for rapid screening of antitumor drugs2023 Zeitschrift für Gastroenterologie article Medicine Hepatocellular Carcinoma Treatment and Prognosis
Paul M. Schneider, Karina Benderski, Alexandros Marios Sofias, Twan Lammers, Barbara Schrörs, Mustafa Diken, +2 more
0citations -
Cancer-Associated Fibroblast-Centric Risk Model Predicts Immunotherapy Resistance in Pancreatic Cancer and Reveals PLOD2 as a Key Stromal Therapeutic Target2025 Frontiers in Bioscience-Landmark article Medicine Pancreatic and Hepatic Oncology Research Open access
Pengwei Cao, Feng Cao, Zhihua null Shui, X. Zhang, Mengjie Lv, Hu Xu, +5 more
2citations -
Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009–20162020 European Journal of Cancer article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Margot T.M. Reinders, Suzanne van Meer, Mark Christiaan Burgmans, Koert Pieter de Jong, Heinz‐Josef Klümpen, Robert Auke de Man, +6 more
30citations
21 results